Geo News, Pakistan | Indian health activists move to prevent Gilead's drug patent Financial Times The Initiative for Medicines, Access & Knowledge in India said it had filed a “pre-grant” application in Calcutta to block a patent application on the drug sofosbuvir, just as Gilead, the US pharmaceutical group that developed the medicine, won ... US group seeks to block Gilead drug patent in India |
